Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease

New England Journal of Medicine

Volumn 334, Issue 5, 1996, Pages 286-291

  Behar, Esther ^a   Chao, Nelson J ^a   Hiraki, Debra D ^a   Krishnaswamy, Shalini ^a   Brown, Byron W ^b   Zehnder, James L ^a   Grumet, F Carl ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; COMPLEMENTARY DNA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; DNA POLYMORPHISM; DNA SEQUENCE; DONOR; GRAFT VERSUS HOST REACTION; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; SIBLING;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BASE SEQUENCE; CELL ADHESION MOLECULES; CHILD; DNA, COMPLEMENTARY; FEMALE; GENOTYPE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0030032105     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199602013340502     Document Type: Article

References (39)

1. Ferrara JLM, Deeg HJ Graft-versus-host disease. N Engl J Med 1991;324: 667-74
2. Chao NJ, Schmidt GM, Niland JC, et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporme and predrusone for prophylaxis of acute graft-versus-host disease. N Engl J Med 1993,329.1225-30.
3. Hansen JA, Anasetti C, Martin PJ, Mickelson EM, Petersdorf E, Thomas ED. Allogeneic marrow transplantation: the Seattle experience In Terasaki PI, Cecka JM, eds. Clinical transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1994:193-209.
4. Sullivan KM. Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Oxford, England: Blackwell Scientific, 1994:339-62.
5. Pierson GR, Elkins WL. Limited polymorphism of minor histocompatibility loci in relation to bone marrow transplantation In: Gale RP, Champlin R, eds Progress in bone marrow transplantation Vol 53 of UCLA symposia on molecular and cellular biology. New York: Alan R. Liss, 1987:307-14.
6. van Els CACM, D'Amaro J, Pool J, et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 1992;35:161-5.
7. Sekimata M, Griem P, Egawa K, Rammensee HG, Takiguchi M. Isolation of human minor histocompatibihty peptides. Int Immunol 1992;4:301-4.
8. Marijt WAF, Veenhof WFJ, Goulmy E, Willemze R, van Rood JJ, Falkenburg JHF. Minor histocompatibihty antigens HA-1, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact. Blood 1993;82 3778-85.
9. van der Harst D, Goulmy E, Falkenburg JHF, et al. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 1994,83:1060-6.
10. Vinci G, Masset M, Semana G, Vernant JP. A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex. Transplantation 1994;58:361-7
11. den Haan JMM, Sherman NE, Blokland E, et al Identification of a graft versus host disease-associated human minor histocompatibility antigen Science 1995;268:1476-80.
12. Stastny P, Nunez G. The role of endothelial and monocyte antigens in kidney transplantation. In: Towaraine JL, Traeger J, Betuel H, et al., eds. Transplant and clinical immunology Amsterdam: Excerpta Medica, 1981:132-9.
13. Brasile L, Zerbe T, Rabin B, Clarke J, Abrams A, Cerilli J. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Transplantation 1985;40:672-5.
14. Cerilli J, Clarke J, Abrams A, Brasile L. Significance, of vascular endothelial cell antigen. Transplant Proc 1987;19:4468-70.
15. Moraes JR, Pettaway C, Stastny P. Prediction of early kidney transplant rejection by a crossmatch with donor skin. Transplantation 1989;48:951-2.
16. Kalil J, Guilherme L, Neumann J, et al. Humoral rejection in two HLA identical living related donor kidney transplants. Transplant Proc 1989;21:711-3.
17. Antibodies to endothelial cells. Lancet 1991,337:649-50.
18. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH Anti-endothelial antibodies and coronary artery disease after cardiac transplantation Lancet 1992;339:1566-70.
19. Behar E, Bryant P, Taidi-Laskowski B, Kalil J, Grumet FC. Cell surface antigen stability of cultured human umbilical vein vascular eudothelial (VEC) cells. Tissue Antigens 1994,44:332-4.
20. Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990;247:1219-22.
21. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 1994;15:490-5.
22. Simmons DL, Walker C, Power C, Pigott R. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med 1990;171:2147-52
23. Stockinger H, Gadd SJ, Eher R, et al. Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 1990; 145:3889-97.
24. Zehnder JL, Hirai K, Shatsky M, McGregor JL, Levitt LJ, Leung LLK The cell adhesion molecule CD31 is phosphorylated after cell activation: down-regulation of CD31 in activated T lymphocytes. J Biol Chem 1992;267:5243-9.
25. Leitner T, Halapi E, Scarlatti G, et al. Analysis of heterogeneous viral populations by direct DNA sequencing Biotechniques 1993;15:120-7.
26. Kirschbaum NE, Gumina RJ, Newman PJ. Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. Blood 1994;84 4028-37
27. Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK. Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets Thromb Haemost 1991;66:700-7.
28. Sullivan KM, Shulman HM, Storb R, et al Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981;57:267-76.
29. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974;18:295-304.
30. Hartl DL. A primer of population genetics 2nd ed Sunderland, Mass.: Sinauer Associates, 1987:23-31.
31. Armitage P, Berry G. Statistical methods in medical research. 3rd ed Oxford, England: Blackwell Scientific, 1994.
32. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley, 1981.
33. Milstein CP, Stemberg AG, McLaughlin CL, Solomon A. Amino acid sequence change associated with genetic marker Inv(2) of human immunoglobulin. Nature 1974;248:160-1.
34. 33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing J Clin Invest 1989;83:1778-81.
35. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY. Bone mar row-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990;323:1818-22
36. Davenport C, Haile A, Kumar V, Bennett M. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells. J Immunol 1995;154:2568-77.
37. Kitajima T, Iwashiro M, Kuribayashi K, Imamura S. The role of CD4+ and CD8+ cells in normal F1 hybrid host in the resistance to lethal graft-versus-host disease induction by transfer of parent spleen cells. Immunol Lett 1994;40:207-10.
38. Gumina RJ, Kirschbaum NE, van Tuinen P, Newman PJ. Localization of the human PECAM-1 gene to the long arm of chromosome 17: relationship to the glycoprotein IIb/IIIa complex and ICAM-2 Thromb Haemost 1993;69: 923. abstract.
39. Zehnder JL, Shatsky M, Leung LL, Butcher EC, McGregor JL, Levitt LJ. Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide. Blood 1995;85:1282-8.